Bulent Karagoz
- 4.6 優秀 • 517 レビュー
- 33年の経験
- トルコ, イスタンブール, Anadolu Medical Center
ビュレント・カラゴズ教授は、ジョンズ・ホプキンス・メディシン提携施設であるアナドル医療センターにて、複雑な肝臓がん症例を専門としています。
- 医療腫瘍学における33年の経験の経験
- 分子標的療法およびがん免疫療法の専門家
- 腫瘍学に関する40件以上の研究論文を発表
- イスタンブール・オカン大学医学部教授
- トルコ医療腫瘍学会会員
- 続きを読む
ビュレント・カラゴズ教授は、ジョンズ・ホプキンス・メディシン提携施設であるアナドル医療センターにて、複雑な肝臓がん症例を専門としています。
タンルクル医師は、化学療法および腫瘍内科学による肝臓がんの治療を専門としています。彼女はがん治療の先進病院であるアナドル・メディカルセンターに勤務しています。
ムスタファ・ソラク医師は、ハジェテペ大学がん研究所でフェローシップ研修を修了し、肝臓がんを含む消化器がんを専門としています。
900件以上の肝臓がん治療を実施 – カプデビラ医師は、テクノン医療センターにおける消化器・肝胆道系がんの専門家です。
Assoc. Prof. Gorkem Turkkan started his medical education at Gülhane Military Medical Academy in 2003 and completed it at Zonguldak Karaelmas (Bülent Ecevit) University Faculty of Medicine in 2009. He completed his specialization at Trakya University Faculty of Medicine, Department of Radiation Oncology and became a radiation oncology specialist in 2016.
After completing his compulsory service, he served as a Lecturer and Head of Department at Muğla Sıtkı Koçman University Faculty of Medicine, Department of Radiation Oncology, from May 2019 to February 2021. Meanwhile, between March and June 2020, he worked as a clinical researcher at Maastricht University Faculty of Medicine Department of Radiation Oncology – MAASTRO Clinic (Netherlands) on stereotactic radiotherapy, thoracic radiotherapy-related lung toxicity and proton therapy. While he was working at İstinye University Faculty of Medicine, Department of Radiation Oncology and Liv Hospital Ulus Radiation Oncology Clinic between March 2021 and April 2023, he received the title of Associate Professor in February 2023. She has been serving her patients at Hisar Hospital Intercontinental since May 2023.
He has performed both traditional radiotherapy and advanced radiotherapy throughout his career. He is one of the experienced physicians in our country in stereotactic radiotherapy and MRI-guided radiotherapy treatments, which have become increasingly popular and used especially recently. So far, he has successfully completed more than 2500 radiotherapy sessions with the MR-Linac device.
He has been a member of the Turkish Society of Radiation Oncology (TROD) since 2013 and the European Society of Radiotherapy and Oncology (ESTRO) since 2015. He has 27 articles published in domestic and international journals, 31 oral-poster presentations presented at national and international congresses, and 5 book chapters published by national and international publishing houses. He taught Term I and Term V undergraduate courses at Muğla Sıtkı Koçman University Faculty of Medicine, postgraduate courses within the scope of Ear Nose and Throat Department Specialization training, and Radiotherapy associate degree courses at İstinye University Vocational School of Health Services. She is currently working on 2 ongoing TÜBİTAK Projects. He is married and has a son.
MEDICAL INTERESTS
MR-Linac
Linac
Stereotactic (Pinpoint) Radiotherapy
Prostate Cancers
Breast Cancers
Lung Cancers
Rectum Cancers
Brain and Spinal Cord Cancers
Head and Neck Cancers
Volumetric Arc Therapy (VMAT)
Intensity Modulated Radiotherapy (IMRT)
Kivanc Derya Peker医師は、Hisar Hospital Intercontinentalにて複雑な肝胆道系疾患を専門とし、200例以上の肝臓手術を執刀しています。
12,000件以上の腹腔鏡手術を執刀 – Ballesta医師は、Centro Médico Teknonにおける肝臓・膵臓がんに対する低侵襲技術のパイオニアです。
ポートフォリオを見る
Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.
Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.
Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.
Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.
Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.
Pfaffenbach教授は、ゾーリンゲン腸腫瘍センターの所長として、年間9,000件以上の内視鏡的介入を実施しています。
パストラナ医師は、ガレニア病院において肝臓がんを専門とする外科腫瘍学の専門医資格を持つ医師であり、権威ある医療機関での豊富な研修経験を有しています。
メリムスキー教授はスーラスキー医療センターの肉腫ユニットを率い、41年の経験の経験を持つ肝臓癌治療の深い専門知識を有しています。
ペレス・シャロン医師は、ソウラスキー医療センターにて化学療法や分子標的療法を含む肝臓がんの高度治療を専門としています。腫瘍学研究にも積極的に貢献し、根拠に基づいた患者ケアの実践に努めています。
Prof. Nadir Arber is a top gastroenterologist from Israel with over 30 years of experience in the field. He is specialized in the prevention, early diagnostics, and treatment of GI cancers, with education from Hebrew University, Tel Aviv University, and NewYork-Presbyterian Center. He has written over 300 papers on his research and is a member of numerous organizations in the field.
Medical Radiation Oncologist
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.
Dr. Jaroslav Tvaruzek is a specialist in robotic surgery. Dr. Tvaruzek is a leading certified expert by Intuitive Surgical - the American produced of the original Da Vinci robots. The doctor is a member of Association of Aesthetic Medicine and Association of Bariatric Surgery.
Dr. Tvaruzek heads the Center of Robotic Surgery located in the St. Zdislava Hospital (the Czech Republic). The doctor has performed over 3,500 robotic surgeries for his practice. Among them are:
Head of Teaching at the Puerto Vallarta Regional Hospital
2020-2023
Medical records manager at the Regional Hospital of Puerto Vallarta 2 months 2020
General practitioner in private medical office
2015-2022
Doctor in charge of weight control clinic
2013-2014
Medical assistant in dermatology clinic
2008-2013
Medical Assistant in Dermatological procedures.
Medical Assistant in minimally invasive surgical procedures
Operation of fractional laser machine - IPIXEL-ER and
facial rejuvenation with IPL.
Experience in laser hair removal with Intense Pulsed Light and
radiofrequency
Experience with ultrasonic cavitation
Experience with ultraviolet (UV) light phototherapy machine for the
treatment of psoriasis and vitiligo.
Experience assisting in Botox and Fillers procedures.
Biomagnet certified by the Higher Institute of Biomagnetism
doctor ISAAC GOIZ DURAN
Experience in clinical records
Training in continuing education and professional development of teachers
Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.
He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.
Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.
| 順位 | 医師 | 経験 | 適合する方 | 特色 | クリニックと所在地 | 診察 |
|---|---|---|---|---|---|---|
| #1 | 33年の経験 | 肝細胞癌症例 | 標的療法と免疫療法を用いた進行肝細胞癌を専門とする。主要大学の教授であり、腫瘍学研究における40本以上の論文を発表している。 | トルコ | から $215 | |
| #2 | 21年の経験 | 肝臓癌化学療法治療 | 肝臓癌の内科的腫瘍学を専門とする。トルコの競争率の高い専門医試験で第3位を獲得し、国際臨床試験を主導している。 | トルコ | から $215 | |
| #3 | 20年の経験 | 消化器癌 | ハジェテペ大学がんセンターにてフェローシップ研修を修了後、MDアンダーソンがんセンターでも研鑽を積む。複雑な消化器がん症例を専門とする。 | トルコ | から $100 | |
| #4 | 26年の経験 | 肝胆膵癌 | 消化器がんを専門とし、研究試験を主導するとともに、スペインの希少腫瘍タスクフォースを共同設立。スウェーデンでのフェローシップ研修を経て、複数の国際学会に所属。 | スペイン | から $615 | |
| #5 | 22年の経験 | 複雑な肝癌症例 | メイヨークリニックのフェローシップ研修を修了した肝胆膵外科医であり、トルコにおけるHPB外科ユニットを設立した。高度な肝切除術および複雑な癌手術を専門とする。 | トルコ | お問い合わせください | |
| #6 | 46年の経験 | 低侵襲肝臓手術 | 腹腔鏡手術手技のパイオニアとして12,000件以上の術式を施行。IFSO認定優秀センター長。世界各国の外科医に高度低侵襲手技を指導。 | スペイン | から $350 | |
| #7 | 34年の経験 | 肝腫瘍インターベンション | 肝臓悪性腫瘍を専門とする高件数内視鏡専門医として、年間9,000件以上の処置を監督。腸管腫瘍センターの委員長を務め、多数の研究論文を発表。 | ドイツ | から $250 | |
| #8 | 6年の経験 | 肝癌の外科的治療 | 肝臓癌を専門とする外科腫瘍学の専門医資格を有し、SMEOの会員であり、2020年よりアナウアック大学にて教育活動に従事している。 | メキシコ | から $200 | |
| #9 | 41年の経験 | 肉腫関連肝癌 | 肉腫関連肝癌の専門家であり、ESMOファカルティメンバー。テルアビブ大学腫瘍科の元学科長として、学術的リーダーシップを発揮。 | イスラエル | から $950 | |
| #10 | 23年の経験 | 進行性肝癌 | 化学塞栓療法および分子標的治療を含む進行肝癌治療を専門とする。根拠に基づく医療のための腫瘍学研究に積極的に携わっている。 | イスラエル | から $825 |